Literature DB >> 35623342

Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer.

Kelly Kersten1, Kenneth H Hu1, Alexis J Combes2, Bushra Samad2, Tory Harwin3, Arja Ray3, Arjun Arkal Rao2, En Cai3, Kyle Marchuk4, Jordan Artichoker4, Tristan Courau2, Quanming Shi5, Julia Belk6, Ansuman T Satpathy7, Matthew F Krummel8.   

Abstract

T cell exhaustion is a major impediment to antitumor immunity. However, it remains elusive how other immune cells in the tumor microenvironment (TME) contribute to this dysfunctional state. Here, we show that the biology of tumor-associated macrophages (TAMs) and exhausted T cells (Tex) in the TME is extensively linked. We demonstrate that in vivo depletion of TAMs reduces exhaustion programs in tumor-infiltrating CD8+ T cells and reinvigorates their effector potential. Reciprocally, transcriptional and epigenetic profiling reveals that Tex express factors that actively recruit monocytes to the TME and shape their differentiation. Using lattice light sheet microscopy, we show that TAM and CD8+ T cells engage in unique, long-lasting, antigen-specific synaptic interactions that fail to activate T cells but prime them for exhaustion, which is then accelerated in hypoxic conditions. Spatially resolved sequencing supports a spatiotemporal self-enforcing positive feedback circuit that is aligned to protect rather than destroy a tumor.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cell exhaustion; antitumor immunity; immunotherapy; tumor microenvironment; tumor-associated macrophages

Mesh:

Year:  2022        PMID: 35623342      PMCID: PMC9197962          DOI: 10.1016/j.ccell.2022.05.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   38.585


  76 in total

1.  TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.

Authors:  Francesca Alfei; Kristiyan Kanev; Maike Hofmann; Ming Wu; Hazem E Ghoneim; Patrick Roelli; Daniel T Utzschneider; Madlaina von Hoesslin; Jolie G Cullen; Yiping Fan; Vasyl Eisenberg; Dirk Wohlleber; Katja Steiger; Doron Merkler; Mauro Delorenzi; Percy A Knolle; Cyrille J Cohen; Robert Thimme; Benjamin Youngblood; Dietmar Zehn
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

2.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

3.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

4.  CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.

Authors:  Gregory L Beatty; Elena G Chiorean; Matthew P Fishman; Babak Saboury; Ursina R Teitelbaum; Weijing Sun; Richard D Huhn; Wenru Song; Dongguang Li; Leslie L Sharp; Drew A Torigian; Peter J O'Dwyer; Robert H Vonderheide
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

5.  Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.

Authors:  Travis A Doering; Alison Crawford; Jill M Angelosanto; Michael A Paley; Carly G Ziegler; E John Wherry
Journal:  Immunity       Date:  2012-11-15       Impact factor: 31.745

6.  Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

Authors:  Hélène Salmon; Juliana Idoyaga; Adeeb Rahman; Marylène Leboeuf; Romain Remark; Stefan Jordan; Maria Casanova-Acebes; Makhzuna Khudoynazarova; Judith Agudo; Navpreet Tung; Svetoslav Chakarov; Christina Rivera; Brandon Hogstad; Marcus Bosenberg; Daigo Hashimoto; Sacha Gnjatic; Nina Bhardwaj; Anna Karolina Palucka; Brian D Brown; Joshua Brody; Florent Ginhoux; Miriam Merad
Journal:  Immunity       Date:  2016-04-19       Impact factor: 31.745

7.  fastp: an ultra-fast all-in-one FASTQ preprocessor.

Authors:  Shifu Chen; Yanqing Zhou; Yaru Chen; Jia Gu
Journal:  Bioinformatics       Date:  2018-09-01       Impact factor: 6.937

8.  A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.

Authors:  Johanna Wagner; Maria Anna Rapsomaniki; Stéphane Chevrier; Tobias Anzeneder; Claus Langwieder; August Dykgers; Martin Rees; Annette Ramaswamy; Simone Muenst; Savas Deniz Soysal; Andrea Jacobs; Jonas Windhager; Karina Silina; Maries van den Broek; Konstantin Johannes Dedes; Maria Rodríguez Martínez; Walter Paul Weber; Bernd Bodenmiller
Journal:  Cell       Date:  2019-04-11       Impact factor: 41.582

9.  TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.

Authors:  Omar Khan; Josephine R Giles; Sierra McDonald; Sasikanth Manne; Shin Foong Ngiow; Kunal P Patel; Michael T Werner; Alexander C Huang; Katherine A Alexander; Jennifer E Wu; John Attanasio; Patrick Yan; Sangeeth M George; Bertram Bengsch; Ryan P Staupe; Greg Donahue; Wei Xu; Ravi K Amaravadi; Xiaowei Xu; Giorgos C Karakousis; Tara C Mitchell; Lynn M Schuchter; Jonathan Kaye; Shelley L Berger; E John Wherry
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

10.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

View more
  5 in total

1.  SET/PP2A signaling regulates macrophage positioning in hypoxic tumor regions by amplifying chemotactic responses.

Authors:  Shaolong Zhang; Jingping Zhou; Pengzhao Shang; Guomeng Zhao; Anlei Wang; Jinlei Mao; Yuhang Tao; Ziyi Chen; Xuehao Wang; Changying Guo
Journal:  Exp Mol Med       Date:  2022-10-12       Impact factor: 12.153

2.  CircMERTK modulates the suppressive capacity of tumor-associated macrophage via targeting IL-10 in colorectal cancer.

Authors:  Mingchen Zhu; Zining Zhu; Pan Jiang; Junyu Zheng; Feng Yan; Jifeng Feng
Journal:  Hum Cell       Date:  2022-09-27       Impact factor: 4.374

3.  Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer.

Authors:  Yangyan Cui; Hanyi Feng; Jiakuan Liu; Jiajun Wu; Rujian Zhu; Ruimin Huang; Jun Yan
Journal:  Front Mol Biosci       Date:  2022-09-08

Review 4.  Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy.

Authors:  Anaïs Vermare; Marion V Guérin; Elisa Peranzoni; Nadège Bercovici
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

5.  Identification of ST3GAL5 as a prognostic biomarker correlating with CD8+ T cell exhaustion in clear cell renal cell carcinoma.

Authors:  Jiakuan Liu; Meiqian Li; Jiajun Wu; Qi Qi; Yang Li; Simei Wang; Shengjie Liang; Yuqing Zhang; Zhitao Zhu; Ruimin Huang; Jun Yan; Rujian Zhu
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.